Spruce Biosciences (SPRB)

• Market cap: $110M
• 1 day: -7.56%
• 5 days: -2.83%
• 1 month: -30.74%
• 3 months: 947.04%
• 6 months: 947.04%
• Year to date: 226.16%
• 1 year: 179.21%
• 5 years: -94.85%
• 10 years: -91.95%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20